Christopher Hanson advises international and domestic clients on regulatory strategies and compliance for medical devices, pharmaceuticals, biological products, cosmetics, animal products, and radiation-emitting electronic products. His broad range of clients include large multinational companies, venture capital firms, industry associations, clinical laboratories, and development-stage companies.
Mr. Hanson has extensive experience counseling clients on interactions with state, federal, and foreign regulatory agencies, including the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), the Federal Trade Commission (FTC), the Centers for Medicare and Medicaid Services (CMS), and the National Institute for Health and Care Excellence (NICE).
Mr. Hanson regularly assists clients with drafting state, federal, and foreign legislation as well as preparing public comments for agency rulemakings, guidance documents, and advisory committees. He provides strategic advice and regulatory due diligence to support corporate transactions and securities filings. He also has experience advising in enforcement matters and conducting global internal investigations and audits of the firm’s life science clients in the United States, Asia, Australia, Europe, and Latin America.
Mr. Hanson is an active firm member having served as Vice Chair of the Summer Associate Program (2015, 2016) in the Washington, DC office. Additionally, he pursues extensive pro bono work related to the lesbian, gay, bisexual, and transgender (LGBT+) community and speaks across the country on issues of LGBT+ diversity and inclusion in the legal community.
He is a graduate of Northwestern University School of Law, where he was elected to the Order of the Coif and graduated in two years. He holds a Masters of Divinity degree from Harvard University, where he was a Presidential Scholar, and an honors undergraduate degree from Yale University. Mr. Hanson previously served as the Chairperson of the Harvard Divinity School Alumni/ae Council.